Skip to main content

Advertisement

Log in

Response to the letter to the Editor concerning our article “High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany”

  • Letter to the Editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cransac A, Aho S, Boulin M (2019) Comments on: high adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany. Support Care Cancer:1–2. https://doi.org/10.1007/s00520-019-04886-y

  2. Feiten S, Chakupurakal G, Feustel HP, Maasberg M, Otremba B, Ehscheidt P, Hensel M, Hansen R, Weide R (2019) High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany. Support Care Cancer 27:4265–4271. https://doi.org/10.1007/s00520-019-04721-4

    Article  PubMed  Google Scholar 

  3. Foulon V, Schoffski P, Wolter P (2011) Patient adherence to oral anticancer drugs: an emerging issue in modern oncology. Acta Clin Belg 66(2):85–96. https://doi.org/10.2143/ACB.66.2.2062525

    Article  CAS  PubMed  Google Scholar 

  4. Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS (2006) Validity of a prescription claims database to estimate medication adherence in older persons. Med Care 44(5):471–477. https://doi.org/10.1097/01.mlr.0000207817.32496.cb

    Article  PubMed  Google Scholar 

  5. Vermeire E, Hearnshaw H, Van Royen P, Denekens J (2001) Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 26(5):331–342

    Article  CAS  Google Scholar 

  6. Banning M (2008) Older people and adherence with medication: a review of the literature. Int J Nurs Stud 45(10):1550–1561. https://doi.org/10.1016/j.ijnurstu.2008.02.009

    Article  PubMed  Google Scholar 

  7. Banning M (2012) Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review. Eur J Cancer Care (Engl) 21(1):10–19. https://doi.org/10.1111/j.1365-2354.2011.01295.x

    Article  CAS  Google Scholar 

  8. Mislang AR, Wildes TM, Kanesvaran R, Baldini C, Holmes HM, Nightingale G, Coolbrandt A, Biganzoli L (2017) Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendations. Cancer Treat Rev 57:58–66. https://doi.org/10.1016/j.ctrv.2017.05.002

    Article  PubMed  Google Scholar 

  9. Wang PS, Benner JS, Glynn RJ, Winkelmayer WC, Mogun H, Avorn J (2004) How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf 13(1):11–19. https://doi.org/10.1002/pds.819

    Article  CAS  PubMed  Google Scholar 

  10. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487–497. https://doi.org/10.1056/NEJMra050100

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

Our work was supported through a restricted grant from Celgene GmbH, Germany. Celgene had no role in gathering, analyzing, or interpreting the data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefan Feiten.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feiten, S., Chakupurakal, G., Feustel, H.P. et al. Response to the letter to the Editor concerning our article “High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany”. Support Care Cancer 28, 3–4 (2020). https://doi.org/10.1007/s00520-019-05126-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-019-05126-z

Navigation